Co-Diagnostics
CODX
5 hedge funds and large institutions have $625K invested in Co-Diagnostics in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0.01% more ownership
Funds ownership: 0.06% → 0.06% (+0.01%)
23% less capital invested
Capital invested by funds: $812K → $625K (-$187K)
29% less funds holding
Funds holding: 7 → 5 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$49.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$45.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$1K |
| 3 |
Morgan Stanley
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $251K | +$49.5K | +501 | +19% |
|
2
HighTower Advisors
Chicago,
Illinois
| $204K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $126K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $36K | +$45.2K | +458 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $8K | +$2.57K | +26 | +35% |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$1K | -17 | Closed |
|
|
7
Morgan Stanley
New York
| – | -$1K | -9 | Closed |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -7 | Closed |
|
CODX Hedge Fund Activity: Q3 2018 in Review
5 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q3 2018, worth a combined $625K — down 23% from $812K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CODX and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $49.5K. The largest seller was Deutsche Bank, exiting entirely with an estimated $1K sold.
- 5 institutional investors held Co-Diagnostics (CODX) as of Q3 2018, down from 7 in Q2 2018.
- Funds reported $625K of Co-Diagnostics stock for Q3 2018, down 23% quarter-over-quarter.
- 1 fund opened new Co-Diagnostics positions in Q3 2018 and 3 closed out, a net change of -2 holders.
- The largest Co-Diagnostics buyer in Q3 2018 was Vanguard Group, an estimated $49.5K added.
- The largest Co-Diagnostics seller in Q3 2018 was Deutsche Bank, an estimated $1K sold.
Based on aggregated 13F filings for Q3 2018.